High Rates of Cannabis Use Found Among Primary Care Patients
The researchers found that 17% of patients reported using cannabis in the past 3 months.
The researchers found that 17% of patients reported using cannabis in the past 3 months.
Cann
Cann Group just released the latest in a series of announcements worthy of a good head scratch.
ASX:CAN
At 7PM Eastern time, June 3, Cann (ASX:CAN) released the news that they'd be re-listing on the ASX.
prostate
This study adds to the growing body of evidence suggesting anticancer properties of cannabinoids that warrants further investigation.
CAMS
The Cannabis As Medicine Survey 2022-2023 (CAMS-22) collected anonymous responses from over 3,300 Australian adults who had used cannabis medically in the past year.
homegrow
While countries like Canada, Uruguay, and several U.S. states have legalised cannabis for adult recreational use, Australia maintains harsh criminal penalties for possession and cultivation in most jurisdictions.
South Africa
In a landmark move for cannabis reform in Africa, South African President Cyril Ramaphosa has officially signed the Cannabis for Private Purposes Act (CfPPA) into law.
odc
From July 1, 2024, all new licence applications must be submitted through a secure client portal with web-based forms.
cannabis tourism
Australia could be primed to become a leader in this specialised niche of medical cannabis tourism.
WM Technology, (weedmaps) announced positive financial results for the first quarter of 2024 and full year 2023 in its latest SEC filings.
HomeGrowAmnesty
With no legal recreational framework, those treating their conditions with cannabis have faced an impossible choice:
Stanley brothers
The Stanley brothers have launched their new brand with a crowd funding campaign in Australia at Birchal.
homegrow
“All adults should be allowed to grow their own cannabis alongside their fruits and vegetables, if they so choose, without the fear of financial or criminal penalties”
ASX:CAN
In the latest announcement from Cann Group (currently suspended - ASX:CAN), the possibility of a leaseback of the Mildura facility has been raised by management.
Cann
Cann Group (ASX:CAN has announced that Chief Executive Officer, Peter Koetsier has given notice of his resignation, for family reasons.
acb
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), together with subsidiary company, MedReleaf Australia, have announced medical cannabis pastilles are now available for doctors to prescribe to patients in Australia. The novel product is produced by Aurora and distributed by MedReleaf Australia. "Australia is the largest nationally legal medical market